tirzepatide sexual function libido study 🚨 New Research Alert! 🚨 From @sexmedresearch For the first time, a GLP-1/GIP medication (tirzepatide) has been shown to successfully treat Persistent Genital Arousal Disorder (PGAD/GPD) — a rare, painful, and often Sex Drive, Erectile Dysfunction, and

It can cover Wegovy for the cardiovascular risk-reduction indication (for adults with established CVD who are overweight or obese) with prior authorization

Do not use more than 15 pieces a day

Human studies are necessary to explore this relationship and other potential impacts on gynecological health

Medication works perfectly Super easy and expected results Works great

Starting with 2 mg per week, increasing to 4 mg, then 8 mg, with the final dose at 12 mg per week The study showed that the more medicine participants took, the more weight they lost

GLP-1 is secreted from L cells in the small intestine upon food stimuli including carbohydrates, lipids, proteins, amino acids, bile acids and short-chain fatty acids